Gout prevalence and predictors of urate-lowering therapy use: Results from a population-based study
Arthritis Research & Therapy Jul 17, 2018
Pisaniello HL, et al. - Researchers ascertained the prevalence of self-reported gout and the key predictors of urate-lowering therapy (ULT) use in those with gout in a representative population survey in South Australia. Only 55% of respondents with gout adhered to ULT despite gout being a common, potentially disabling joint disease. Guidance on prescribing strategy in clinical practice and on the quality of gout care in the community could be provided by the identification of key predictors of ULT.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries